Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
Go back to Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026| (NASDAQ: BMEA) | Delayed: 1.47 +0.08 (5.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.39 | 52 Week High | $ | |||
| Open | $1.40 | 52 Week Low | $ | |||
| Day High | $1.50 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $ | |||
| Volume | 1,503,022 | |||||
